Single-Stage Clarification
The 3M Harvest RC clarifier condenses three process steps into a single-stage purification of recombinant protein therapeutics.
The 3M Harvest RC Clarifier
The 3M Harvest RC clarifier from 3M Health Care uses a proprietary fibrous chromatography media to condense three process steps into a single-stage purification of recombinant protein therapeutics.
The clarifier provides monoclonal antibody recovery of more than 95% and can be used with cultures with different cell densities, high-packed cell volumes, and cell culture characteristics. The quaternary ammonium functionalized polypropylene fiber, and 0.2 µm PES membrane, provides scalable clarification from discovery to commercial manufacturing scale.
The clarifier introduces chromatographic separation earlier in the process to remove soluble impurities, resulting in cleaner effluent, the company reports.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
July 16th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.
